Sun Pharmaceutical Industries expands the label for Ilumya (tildrakizumab-asmn) to include treatment for adults with active ...

Strides Pharma reports a 17.1% YoY revenue increase in Q2, reaching ₹1,429 crore. Net profit rises 2% amidst stronger growth ...

Cybersecurity experts emphasize the significance of human oversight in AI-driven security and the critical need for effective ...

Merck is set to increase its revenue forecast for the next decade due to successful clinical trials and new acquisitions, ...

Sun Pharmaceutical Industries has been ordered to cease production of ophthalmic products at its Assam plant due to quality ...

India's pharmaceutical exports rose 3% to $8.04 billion in Q2 2027-28, driven by strong demand in European markets, ...

The Indian Patent Office has rejected a patent application for the BPaL regimen, a groundbreaking treatment for ...

In response to safety issues surrounding cough syrups in India, the CDSCO mandates strict monitoring of high-risk solvents ...